A collection of stock notes from around the web.
The Fool takes a look at two relatively unknown medical companies: Dexom and Inari. Dexcom is already up huge since its IPO 15 years ago but Inari just went IPO this year.
The Fool points out that Innovate Industrial Partners is a growth stock that pays a nice dividend.
Cloudera has a $16 to $19 price target.
The Fool owns shares of and recommends Grower Generation
The Fool is out with a discussion of three companies that may turn into 10 baggers one day. One of the companies is Magnite.
The Fool still owns shares of Criteo, which had a decent quarter in the COVID environment.
The Fool is out with a small update on Aimmune Therapeutics. They do not own shares.